Key facts
- It has raised $21.2M; the latest was Early Stage VC ($16.6M) in Dec 2025.
- Notable investors include Flare Capital Partners, Maverick Ventures, EPIC Ventures, Jim Lacy, LRVHealth — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Daffodil
- ·The full record, as it builds
Funding rounds
No funding rounds for Daffodil are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Daffodil
Developer of an artificial intelligence-powered platform designed for healthcare pricing and administration. The company's platform specializes in real-time repricing of claims, configuration of pricing rules, and benchmarking of the repriced claims, enabling businesses to have access to automated pricing operations.
- Sector
- Financial Services
- HQ
- San Jose, CA, United States
- Founded
- 2023
- Employees
- 11
- Website
- daffodilhealth.co/
- Ownership
- Privately Held (backing)
Daffodil doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Daffodil shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Daffodil in its N-PORT filings yet. We sweep new filings monthly.